These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2566475)

  • 1. Central nervous system kinetics of atenolol and metoprolol in the dog during long term treatment.
    Abrahamsson T; Lignell E; Mikulski A; Olovson SG; Regårdh CG
    Drug Metab Dispos; 1989; 17(1):82-6. PubMed ID: 2566475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations.
    Eriksson M; Nyberg G; Lidman K; Olofsson B; Bergstrand R
    Blood Press Suppl; 1993; 1():16-21. PubMed ID: 7909705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
    Nordström M; Abrahamsson T; Ervik M; Forshult E; Regårdh CG
    J Pharmacol Exp Ther; 1993 Jul; 266(1):147-52. PubMed ID: 8331554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
    Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
    J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Adrenoreceptor-blocking agents and the blood-brain barrier.
    Cruickshank JM; Neil-Dwyer G; Cameron MM; McAinsh J
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():453s-455s. PubMed ID: 7449299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of beta-blockade with metoprolol and atenolol: influence of drug oxidation.
    Freestone S; Lennard MS; Silas JH; Ramsay LE
    Postgrad Med J; 1983; 59 Suppl 3():36-7. PubMed ID: 6647208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.
    Kaila T; Marttila R
    Br J Clin Pharmacol; 1993 May; 35(5):507-15. PubMed ID: 8099803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pharmacodynamic variables following oral versus transdermal administration of atenolol to healthy cats.
    Macgregor JM; Rush JE; Rozanski EA; Boothe DM; Belmonte AA; Freeman LM
    Am J Vet Res; 2008 Jan; 69(1):39-44. PubMed ID: 18167085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol.
    van Zwieten PA; Timmermans PB
    J Cardiovasc Pharmacol; 1979; 1(1):85-96. PubMed ID: 94385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbits.
    Scism JL; Powers KM; Artru AA; Chambers AC; Lewis L; Adkison KK; Kalhorn TF; Shen DD
    Drug Metab Dispos; 1997 Dec; 25(12):1337-46. PubMed ID: 9394022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of atenolol in clinically normal cats.
    Quiñones M; Dyer DC; Ware WA; Mehvar R
    Am J Vet Res; 1996 Jul; 57(7):1050-3. PubMed ID: 8807020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chiral assay of atenolol present in microdialysis and plasma samples of rats using chiral CBH as stationary phase.
    Fornstedt T; Hesselgren AM; Johansson M
    Chirality; 1997; 9(4):329-34. PubMed ID: 9275311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in the pharmacokinetics of atenolol and metoprolol.
    Ledermann H; Bippi H; Boekens H; Frölich JC; Herrmann H; Schmitt-Landherr K
    Arzneimittelforschung; 1985; 35(5):848-51. PubMed ID: 4026908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.
    Masaoka Y; Tanaka Y; Kataoka M; Sakuma S; Yamashita S
    Eur J Pharm Sci; 2006 Nov; 29(3-4):240-50. PubMed ID: 16876987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
    Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
    Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
    Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenoceptor blockers and the blood-brian barrier.
    Neil-Dwyer G; Bartlett J; McAinsh J; Cruickshank JM
    Br J Clin Pharmacol; 1981 Jun; 11(6):549-53. PubMed ID: 6115665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redistribution of sufentanil to cerebrospinal fluid and systemic circulation after epidural administration in dogs.
    Stevens RA; Petty RH; Hill HF; Kao TC; Schaffer R; Hahn MB; Harris P
    Anesth Analg; 1993 Feb; 76(2):323-7. PubMed ID: 8424509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with beta-blockers--the value of an even plasma concentration over 24 h.
    Agewall S; Kendall M
    J Clin Pharm Ther; 1997 Jun; 22(3):171-9. PubMed ID: 9447471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.